Moderna’s 370% Rally Has Cost Short Sellers $1.5 Billion in 2020

(Bloomberg) -- Those betting against high-flying vaccine developer Moderna Inc. have taken their lumps this year with the biotech’s 370% rally costing short sellers almost $1.5 billion, according t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.